In this project a molecular diagnostic test, named RNA Disruption Assay (RDA) will be developed. RDA measures an individual patient’s tumor response to chemotherapy and accurately predicts whether the drug regimen will lead to the elimination of the disease after the completion of the treatment. RDA is a measure of RNA structural integrity and is derived from RNA electropherograms. This project includes the assessment and a preliminary mathematical analysis of patterns within the RNA electropherograms to generate RDA values of responders and non-responders as well as to distinguish drug effects from other extraneous effects including sample concentration and degradation. In order to commercialize the intellectual property related to RDA, Rna Diagnostics Inc. requires mathematical and statistical expertise to develop and validate an algorithm derived from RNA electropherograms.
Dr. Mu Zhu
Statistics / Actuarial sciences
University of Waterloo
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.